{"name":"Hopital Charles Nicolle","slug":"hopital-charles-nicolle","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Norepinephrine (10 µg boluses)","genericName":"Norepinephrine (10 µg boluses)","slug":"norepinephrine-10-g-boluses","indication":"Acute hypotension in critical care settings","status":"marketed"}]}],"pipeline":[{"name":"Norepinephrine (10 µg boluses)","genericName":"Norepinephrine (10 µg boluses)","slug":"norepinephrine-10-g-boluses","phase":"marketed","mechanism":"Norepinephrine is a catecholamine that binds to alpha and beta adrenergic receptors to increase heart rate, cardiac contractility, and peripheral vasoconstriction, thereby raising blood pressure and improving tissue perfusion.","indications":["Acute hypotension in critical care settings","Cardiogenic shock","Septic shock (adjunctive therapy)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5EVHYtODN5ZzdQTlp5ZmVCNkNDd19KSEpmeDJIRmRNUDljaXp6REpRWHpMdkd3T2ZEWVFKUW9KZlBKdDl4TUV1VXYwdHBhcXlvM09xdzFUOVdZd2NQLWFr?oc=5","date":"2026-02-06","type":"pipeline","source":"Nature","summary":"Bioequivalence assessment between two formulations of a film-coated fixed-dose combination of metformin and vildagliptin (850/50mg) in healthy Tunisian subjects under fed conditions - Nature","headline":"Bioequivalence assessment between two formulations of a film-coated fixed-dose combination of metformin and vildagliptin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPbXNEVklfNWtqZlQ0UGpZXzB1cUQ1WkNhMXpjczg3WkZZMkpnM1FVcE5GUGZadzV3QVFlNTliQzh1VG1rN196RGxVR1pGX2I2N2xFY3BXS1RiU1VuQzJNNjF1a3N2MWtqZTdKenM3dy1WeTA5NjBTeS1Kel9XSVVONHVzd1JjcENDZEt1SlUwc2Y4dlJWczVEMVRDektaNjhFVEV5OHRWRWh2MUtYWDRHYmVrWTBDcVl4OERHYUpmcTNpbkpnczRpWlFlRWpKaWdJ?oc=5","date":"2024-03-29","type":"regulatory","source":"Cureus","summary":"Enhancing Hospital Pharmacy Operations Through Lean and Six Sigma Strategies: A Systematic Review - Cureus","headline":"Enhancing Hospital Pharmacy Operations Through Lean and Six Sigma Strategies: A Systematic Review","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}